journal article·2015-05-04

Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin–superoxide dismutase–catalase–carbonic anhydrase

C. Guo, M. Gynn, T. M. S. Chang

Publisher page

Abstract

We report a novel method to simultaneously extract superoxide dismutase (SOD), catalase (CAT), and carbonic anhydrase (CA) from the same sample of red blood cells (RBCs). This avoids the need to use expensive commercial enzymes, thus enabling a cost-effective process for large-scale production of a nanobiotechnological polyHb-SOD-CAT-CA complex, with enhancement of all three red blood cell functions. An optimal concentration of phosphate buffer for ethanol-chloroform treatment results in good recovery of CAT, SOD, and CA after extraction. Different concentrations of the enzymes can be used to enhance the activity of polyHb-SOD-CAT-CA to 2, 4, or 6 times that of RBC.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hemoglobin structure and function · Enzyme function and inhibition · Neonatal Health and Biochemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (25)

Show source-provided references
1. Alayash AI. · Antioxid Redox Signal · 2004 · 6 · 94110.1089/ars.2004.6.941 ↗
2. Arthurs G · Critical Care & Pain · 2005 · 5 · 207
3. Bian Y · Artif Cells Blood Substit Immobil Biotechnol · 2012 · 40 · 2810.3109/10731199.2011.582041 ↗
4. 10.3109/21691401.2014.96455410.3109/21691401.2014.964554 ↗
5. 10.1126/science.146.3643.52410.1126/science.146.3643.524 ↗
6. 10.1016/S0006-291X(71)80260-710.1016/S0006-291X(71)80260-7 ↗
7. Chang TM. 2007. Artificial cells: Biotechnology, nanotechnology, blood substitutes, regenerative medicine, bioencapsulation, cell/stem cell therapy. World Scientific Publisher/Imperial College Press, p. 455. Available at http://www.medicine.mcgill.ca/artcell/2007%20ebook%20artcell%20web.pdf. Accessed on April 2 2015.10.1142/6395 ↗
8. 10.3109/10731199.2012.66240810.3109/10731199.2012.662408 ↗
9. Chang TM · 2013 · 110.1142/9789814472869_0001 ↗
10. 10.1016/j.aca.2013.08.00510.1016/j.aca.2013.08.005 ↗
11. da Costa Ores J · Chemosphere · 2012 · 88 · 25510.1016/j.chemosphere.2012.03.059 ↗
12. D’Agnillo F · Nat Biotechnol · 1998 · 16 · 66710.1038/nbt0798-667 ↗
13. Foulkes E · Series B-Biological Sciences · 1949 · 136 · 43510.1098/rspb.1949.0035 ↗
14. Geers C · Physiol Rev · 2000 · 80 · 68110.1152/physrev.2000.80.2.681 ↗
15. 10.1080/1073119090274224010.1080/10731190902742240 ↗
16. Jahr JS · J Trauma · 2008 · 64 · 148410.1097/TA.0b013e318173a93f ↗
17. Kim HW · 2014
18. 10.1002/bit.26046021110.1002/bit.260460211 ↗
19. Miller H · Biochem J · 1958 · 68 · 27510.1042/bj0680275 ↗
20. 10.1016/j.jamcollsurg.2008.09.02310.1016/j.jamcollsurg.2008.09.023 ↗
21. Paco L · Biotechnol J · 2009 · 4 · 146010.1002/biot.200900100 ↗
22. Powanda DD · Artif Cells Blood Substit Immobil Biotechnol · 2002 · 30 · 2310.1081/BIO-120002725 ↗
23. 10.1097/00005373-200112000-0002010.1097/00005373-200112000-00020 ↗
24. Ugwu SO · Pharm Technol · 2004 · 28 · 86
25. Zhu H · Artif Cells Blood Substit Immobil Biotechnol · 2010 · 38 · 5710.3109/10731191003634232 ↗